Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ГБОУ ВПО Санкт-Петербургский государственный педиатрический медицинский университет Минздрава РФ
Список исп. литературыСкрыть список 1. Agras S, Oliveau DC. Primary hyperparathyroidism and psychosis. Canad Med Ass J 1964; 91: 1366–7. 2. Karpati G, Frame B. Neuropsychiatric disorders in primary hyperparathyroidism. Clinical analysis with review of the literature. Arch Neurol 1964; 10: 387–97. 3. Feldman F, Mitchell W, Soll S. Psychosis, Cushing\'s syndrome and hyperparathyroidism. Canad Med Ass J 1968; 98 (9): 508–11. 4. Petersen P. Psychiatric disorders in primary hyperparathyroidism. J Clin Endocrin Metab 1968; 28: 1491–5. 5. Gatewood JW, Organ CH, Mead BT. Mental changes associated with hyperparathyroidism. Am J Psychiat 1975; 132 (2): 129–32. 6. Lee D, Zawada ET, Kleeman R et al. The pathophysiology and clinical aspects of hypercalcemic disorders. West J Med 1978; 129: 278–320. 7. Borer MS, Bhanot VK. Hyperparathyroidism: neuropsychiatric manifestations. Psychosom 1985; 26 (7): 597–601. 8. Velasco PJ, Manshadi M, Breen K et al. Psychiatric aspects of parathyroid disease. Psychosom 1999; 40 (6): 486–90. 9. Walker MD, McMahon DJ, Inabnet WB et al. Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrin Metab 2009; 94 (6): 1951–58. 10. Hurst K. Primary hyperparathyroidism as a secondary cause of depression. J Am Board Fam Med 2010; 23 (5): 677–80. 11. Lea C, Christine E. New onset of neuropsychiatric symptoms in the elderly: possible primary hyperparathyroidism. Psychosomat 2002; 43 (5): 413–7. 12. Garfinkel P, Ezrin C, Stancer H. Hypothyroidism and hyperparathyroidism associated with lithium. Lancet 1973; 3: 331–2. 13. Franks R, Dubovsky S, Lifshitz M et al. Long-term lithium carbonate therapy causes hyperparathyroidism. Arch Gen Psychiat 1982; 39: 1074–7. 14. Rifai MA, Moles JK, Harrington DP. Lithium-induced hypercalcemia and parathyroid dysfunction. Psychosomat 2001; 42 (4): 359–61. 15. Suliburk JW, Perrier ND. Primary hyperparathyroidism. Oncologist 2007; 12: 644–53. 16. Potts JT. Diseases of the parathyroid gland and other hyper- and hypocalcemic disorders. Harrison\'s principles of internal medicine. 15th ed. NY, McGraw-Hill Med 2001; p. 2205–20. 17. Ростомян Л.Г., Рожинская Л.Я., Мокрышева Н.Г. и др. Эпидемиология первичного гиперпаратиреоза. Лечащий врач. 2010; 11 (10): 25–8. 18. Mazzaglia PJ, Berber E, Kovach A et al. The changing presentation of hyperparathyroidism over 3 decades. Arch Surg 2008; 143: 260–6. 19. Heath H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med 1980; 302 (4): 189–93. 20. Романчишен А.Ф., Матвеева З.С. Клинические проявления гиперпаратиреоза и размеры опухолей околощитовидных желез. Вестн. хирургии им. И.И.Грекова. 2006; 2: 37–40. 21. Jorde R, Bonaa KH, Sundsfjord J. Primary hyperparathyroidism detected in a health screening. The Tromso study. J Clin Epidem 2000; 53: 1164–9. 22. Coker LH, Rorie K, Cantley L et al. Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg 2005; 242 (5): 642–50. 23. Лесняк О.М. Постменопаузальный остеопороз. Гинекология. 2004; 6 (3): 124–9. 24. Watson LC, Marx CE. New onset of neuropsychiatric symptoms in the elderly: possible primary hyperparathyroidism. Psychosomat 2002; 43 (5): 413–7. 25. Bilezikian JP, Brandi ML, Rubin M et al. Primary hyperparathyroidism: new concepts in cinical, densitometric and biochemical features. J Intern Med 2005; 257: 6–17. 26. Романчишен А.Ф., Матвеева З.С. Сочетание заболеваний щитовидной железы и бессимптомных аденом околощитовидных желез. Вестн. хирургии им. И.И.Грекова. 2006; 1: 40–2. 27. Беляева А.В., Рожинская Л.Я. Гиперкальциемия и гиперкальциемический криз. Справочник поликлин. врача. 2008; 7: 4–7. 28. Cope O. The story of hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med 1966; 21: 1174–82. 29. Carnevale V, Romagnoli E, Pipino M еt al. Primary hyperparathyroidism. Clin Ter 2005; 156 (5): 211–26. 30. Okamoto T, Gerstein HC, Obara T. Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism: a systematic overview of the literature. Endocrine J 1997; 44 (3): 367–74. 31. Mandel MM. Recurrent psychotic depression associated with hypercalcemia and parathyroid adenoma. Am J Psychiat 1960; 117: 234. 32. Hockaday TD, Keynes WM, McKenzie JK. Catatonic stupor in elderly woman with hyperparathyroidism. Br Med J 1966; 1 (5479): 85–7. 33. Cooper AF, Schapira K. Case report: depression, catatonic stupor, and EEG changes in hyperparathyroidism. Psychol Med 1973; 3 (4): 509–15. 34. Wilhelm SM, Lee J, Prinz RA. Major depression due to primary hyperparathyroidism: a frequent and correctable disorder. Am Surg 2004; 70: 175–9. 35. Devaris DP, Mehlman I. Psychiatric presentations of endocrine and metabolic disorders. Primary Care 1979; 6: 245–65. 36. Bresler SA. Hyperparathyroidism and psychosis: possible prelude to murder. J Forensic Sci 2000; 45 (3): 728–30. 37. Brown RS, Fischman A, Showalter CR. Primary hyperparathyroidism, hypercalcemia, paranoid delusions, homicide, and attempted murder. J Forensic Sci 1987; 32 (5): 1460–3. 38. Goyal A, Chumber S, Tandon N et al. Neuropsychiatric manifestations in patients of primary hyperparathyroidism and outcome following surgery. Indian J Med Sci 2001; 55 (12): 677–86. 39. Geffken GR, Ward HE, Staab JP et al. Psychiatric morbidity in endocrine disorders. Psychiat Clin North Am 1998; 21: 473–89. 40. Silverberg SJ. Non-classical target organs in primary hyperparathyroidism. J Bone Miner Res 2002; 17 (2): 117–25. 41. Lobo-Escolar A, Campayo A, Gуmez-Biel CH et al. Thyroid and parathyroid diseases and psychiatric disturbance, thyroid and parathyroid diseases – new insights into some old and some new issues. Dr. Laura Ward (ed.) 2012; p. 239–58. 42. Joborn C, Hetta J, Palmér M et al. Psychiatric symptomatology in patients with primary hyperparathyroidism. Ups J Med Sci 1986; 91 (1): 77–87. 43. McAllion SJ, Paterson CR. Psychiatric morbidity in primary hyperparathyroidism. Postgrad Med J 1989; 65 (767): 628–31. 44. Mundy GR, Martin TJ. The hypercalcemia of malignancy: pathogenesis and management. Metabolism 1982; 31 (12): 1247–77. 45. Alarcon RD, Franceschini JA. Hyperparathyroidism and paranoid psychosis: case report and review of the literature. Br J Psychiat 1984; 145: 477–86. 46. Bilezikian JP. Primary hyperparathyroidism: surgical vs medical management. Drug Ther Hosp 1982; 7: 41–8. 47. Joborn C, Hetta J, Niklasson F et al. Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism. Psychoneuroendocrin 1991; 16: 311–22. 48. Беневоленская Л.И. Остеопороз – актуальная проблема медицины. Остеопороз и остеопатии. 1998; 1: 4–7. 49. Perkins DO. Antipsychotic-induced hyperprolactinemia: pathophysiology and clinical consequences. Advanced Stud Med 2004; 4 (10): 982–6. 50. Halbreich U, Kinon BJ, Gilmore JA et al. Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrin 2003; 28 (1): 53–67. 51. Naidoo U, Goff DC, Klibanski A. Hyperprolactinemia and bone mineral density: the potencial impact of antipsychotic agents. Psychoneuroendocrin 2003; 2: 97–108. 52. Lean M, Smedt G. Schizophrenia and osteoporosis. Int Clin Psychopharmacol 2004; 19 (1): 31–5. 53. Magliola L, Forte LR. Prolactin stimulation of parathyroid hormone secretion in bovine parathyroid cells. Am J Physiol 1984; 247 (5 Pt 1): 675–80. 54. Isaac R, Merceron RE, Caillens G еt al. Effect of parathyroid hormone on plasma prolactin in man. J Clin Endocrin Metab 1978; 47 (1): 18–23. 55. Adams ND, Garthwaite TL, Gray RW et al. The interrelationshi pamongprolactin, 1,25-dihydroxyvitamin D3 and parathyroid hormone in humans. J Clin Endocrin Metab 1979; 49: 628–30. 56. Carling T, Kindmark A, Hellman P et al. Vitamin D receptor genotypes in primary hyperparathyroidism. Nature Med 1995; 1: 1309–11. 57. Дубровина Я.А., Рожинская Л.Я., Ростомян Л.Г. Современные представления об этиологии, патогенезе, клинической картине, диагностике первичного гиперпаратиреоза. Лечащий врач. 2009; 3: 22. 58. Carling T, Ridefelt P, Hellman P еt al. Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J Clin Endocrin Metab 1997; 82: 1772–5.